C1Add image
CJC-1295 No DAC + Ipamorelin Blend
PerformanceBlendComponents: CJC-1295 (No DAC), Ipamorelin
The most popular GH-stimulation blend — GHRH analog plus selective GHRP, in a single vial.
Half-life
1 h
Common dose
100 – 300 mcg
Dosing frequency
Daily
Administration
Subcutaneous
How it works
CJC-1295 No DAC binds the GHRH receptor while Ipamorelin binds the ghrelin receptor on pituitary somatotrophs. Activation of both pathways produces a synergistic, larger GH pulse than either alone.
Protocol notes
Typical dosing: ~100 mcg each, 1–3 times daily subcutaneously — most commonly pre-bed and post-workout. 8–16 week cycles.
Reported side effects
Combined profile of both: water retention, transient flushing, mild numbness, injection-site reactions.